Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial
2005 ◽
Vol 6
(10)
◽
pp. 757-764
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2013 ◽
Vol 87
(2)
◽
pp. S571
Keyword(s):
2017 ◽
Vol 99
(3)
◽
pp. 590-595
◽
Keyword(s):
2014 ◽
Vol 50
(11)
◽
pp. 1098-1103
◽
Keyword(s):
2001 ◽
Vol 51
(3)
◽
pp. 85
◽
Keyword(s):
1998 ◽
Vol 47
(2)
◽
pp. 145-148
◽
Keyword(s):